Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Microbios ; 94(378): 95-102, 1998.
Article in English | MEDLINE | ID: mdl-9785488

ABSTRACT

The feasibility of constructing attenuated mutants of Staphylococcus aureus with two temperature-sensitive (ts) lesions for ultimate development of a live-attenuated strain was investigated. Temperature-sensitive S. aureus strain G/1/2, which grows well at 31 degrees C but does not replicate at 37 degrees C, was subjected to chemical mutagenesis. After two enrichment cycles, fifteen mutants able to grow at 25 degrees C but unable to grow at 31 degrees C, were identified. Growth curves with temperature shifts from 25 to 31 degrees C, and from 31 to 37 degrees C confirmed that these were mutants with two lesions (dts), each with a different cut-off temperature. The reversion frequency of mutant G/1/2 at 37 degrees C was 2 x 10(-6) whereas those of several dts mutants were much lower (dts7: 7 x 10(-9) and dts12: 1 x 10(-9)). There was no increase in ts mutation reversion rate in response to prolonged incubation at 37 degrees C. The data support the further development of these mutants for use as a stable attenuated vaccine.


Subject(s)
Bacterial Vaccines/genetics , Point Mutation/immunology , Staphylococcal Infections/prevention & control , Staphylococcus aureus/genetics , Animals , Bacterial Vaccines/immunology , Cattle , Hot Temperature , Nitroso Compounds/pharmacology , Phenotype , Sensitivity and Specificity , Staphylococcal Infections/immunology , Staphylococcus aureus/growth & development , Staphylococcus aureus/immunology , Vaccines, Attenuated/genetics , Vaccines, Attenuated/immunology
2.
Curr Microbiol ; 27(3): 125-9, 1993 Sep.
Article in English | MEDLINE | ID: mdl-23835744

ABSTRACT

Temperature-sensitive (ts) mutants ofStaphylococcus aureus were isolated after mutagenesis with nitrosoguanidine and two cycles of enrichment with Penicillin G and D-Cycloserine. The mutants expressed tight, coasting, and leaky phenotypes on solid media. In broth, however, most exhibited coasting for a limited number of generations. The reversion frequency of selected ts mutants was less than 10(-6). Intraperitoneal (i.p.) immunization with ts mutant G/1/2 conferred significant protection (0 dead/6 total vs. 7/7, immunized vs. control; p=0.0006) from lethal i.p. challenge with the parental wild-type (wt)S. aureus suspended in 5% porcine mucin, performed 28 days after i.p. administration of 10(8) colony-forming units. Protection induced by mutants of coasting phenotype was higher and lasted longer than that induced by mutants of the tight phenotype. The results of this study demonstrate that ts mutants ofS. aureus can be obtained and that ts mutants are able to induce protective immunity from subsequent challenge with the parental wt strain.

3.
Infection ; 20(6): 360-4, 1992.
Article in English | MEDLINE | ID: mdl-1293058

ABSTRACT

The therapeutic efficacy of liposomal cefoperazone against Pseudomonas aeruginosa was investigated in a granulocytopenic mouse model of acute lung infection. Granulocytopenia was induced in mice by intraperitoneal (i.p.) injection of 200 mg/kg cyclophosphamide. Mice were challenged by exposure to an aerosol containing P. aeruginosa and were treated i.p. with liposomal cefoperazone prepared by the dehydration-rehydration method. The half-life of free cefoperazone in the lungs following i.p. administration of the liposomal drug was significantly lengthened (13 min vs. 261 min), and the cefoperazone activity in the lungs remained above the MIC longer after administration of liposomal cefoperazone than after treatment with cefoperazone. Liposomal cefoperazone was more effective than cefoperazone alone in preventing death of granulocytopenic mice from lethal pulmonary challenge with P. aeruginosa (75% vs. 38% survival, p = 0.031). Finally, P. aeruginosa was cleared faster from the lungs of mice treated with liposomal cefoperazone when compared with those treated with cefoperazone. This study shows that incorporation of cefoperazone into liposomes enhances the activity of the antibiotic against P. aeruginosa in a granulocytopenic host.


Subject(s)
Agranulocytosis/complications , Cefoperazone/administration & dosage , Lung Diseases/drug therapy , Pseudomonas Infections/drug therapy , Acute Disease , Animals , Cefoperazone/pharmacokinetics , Cefoperazone/pharmacology , Drug Carriers , Half-Life , Liposomes , Lung/metabolism , Lung/microbiology , Lung Diseases/complications , Mice , Pseudomonas Infections/complications
4.
J Gen Microbiol ; 133(10): 2835-41, 1987 Oct.
Article in English | MEDLINE | ID: mdl-3130459

ABSTRACT

The specificity of the enhancement in lung defences after local immunization of mice with three temperature-sensitive (ts) mutants of Pseudomonas aeruginosa was investigated. The three selected mutants display altered growth characteristics when transferred from 29 degrees C to mammalian body temperature. Mice immunized with the live ts mutants by aerosol exposure or multiple intranasal inoculations were challenged with aerosols containing wild-type (wt) P. aeruginosa. Aerosol immunization with ts mutant A/10/25 significantly enhanced the lung clearance of the wt but did not enhance the clearance of either Klebsiella pneumoniae or Staphylococcus aureus. Aerosol immunization with ts mutants D/1/8 or E/9/9 enhanced the lung defences against the parental wt (of identical immunotype 1) but not against immunotype 4; similarly, intranasal immunization enhanced the lung defences against the parental wt but not against immunotypes 4 or 5. We conclude that local immunization with ts mutants of P. aeruginosa enhances lung defences against the wt in a genus- and immunotype-specific fashion. It is suggested that local immunity may play a central role in immunoprophylaxis against P. aeruginosa lung infection.


Subject(s)
Immunization , Lung/immunology , Pseudomonas aeruginosa/immunology , Administration, Inhalation , Aerosols , Animals , Antibodies, Bacterial/analysis , Enzyme-Linked Immunosorbent Assay , Immunoglobulin G/analysis , Mice , Mutation
SELECTION OF CITATIONS
SEARCH DETAIL